Page last updated: 2024-08-18

pyrazolanthrone and Cardiotoxicity

pyrazolanthrone has been researched along with Cardiotoxicity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, JX; Guo, Y; Han, FH; Hu, YH; Li, W; Liu, J; Liu, PQ; Lu, J; Wang, JJ; Wang, PX	1

Other Studies

1 other study(ies) available for pyrazolanthrone and Cardiotoxicity

Article	Year
sFRP1 protects H9c2 cardiac myoblasts from doxorubicin-induced apoptosis by inhibiting the Wnt/PCP-JNK pathway. Acta pharmacologica Sinica, 2020, Volume: 41, Issue:9 Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Cardiotoxicity; Cell Line; Doxorubicin; Intercellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Male; Membrane Proteins; Rats, Sprague-Dawley; Wnt Signaling Pathway	2020

Article

Year

sFRP1 protects H9c2 cardiac myoblasts from doxorubicin-induced apoptosis by inhibiting the Wnt/PCP-JNK pathway.

Acta pharmacologica Sinica, 2020, Volume: 41, Issue:9

Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Cardiotoxicity; Cell Line; Doxorubicin; Intercellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Male; Membrane Proteins; Rats, Sprague-Dawley; Wnt Signaling Pathway

2020